
38.32 Delayed Data As of 6:30pm ET | ![]() Today’s Change | 33.97 Today|||52-Week Range 44.90 | -12.21% Year-to-Date |
Better Buy: Pfizer vs. Bristol-Myers Squibb Dec 08 / MotleyFool.com - Paid Partner Content | Better Buy: Amgen vs. Pfizer Dec 04 / MotleyFool.com - Paid Partner Content |
3 Dividend Stocks You Can Safely Hold for Decades Dec 06 / MotleyFool.com - Paid Partner Content | 3 Top Growth Stocks to Buy in December Dec 03 / MotleyFool.com - Paid Partner Content |
Why Sorrento Therapeutics Was Right to Reject Takeover Bids With A 245% Premium Dec 05 / MotleyFool.com - Paid Partner Content | Here's Why Lexicon Pharmaceuticals Is Tumbling Today Dec 02 / MotleyFool.com - Paid Partner Content |
Previous close | 38.29 |
Today’s open | 38.10 |
Day’s range | 38.10 - 38.38 |
Volume | 14,971,279 |
Average volume (3 months) | 21,169,846 |
Market cap | $211.9B |
Earnings growth (last year) | -46.78% |
Earnings growth (this year) | -1.55% |
Earnings growth (next 5 years) | +8.00% |
Revenue growth (last year) | +2.10% |
P/E ratio | 13.4 |
Price/Sales | 4.86 |
Price/Book | 3.45 |
Today’s change | Today’s % change | |
---|---|---|
NVSNovartis | +0.46 | +0.50% |
MRKMerck | -0.13 | -0.15% |
BMYBristol-Myers Squibb | +1.33 | +2.22% |
ABBVAbbVie | -0.54 | -0.62% |
Next reporting date | January 28, 2020 |
EPS forecast (this quarter) | $0.57 |
Annual revenue (last year) | $53.6B |
Annual profit (last year) | $11.2B |
Net profit margin | 20.77% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |